Alli Lifestyle Marketing Plan Could Prompt Copies – Researchers
This article was originally published in The Tan Sheet
Executive Summary
GlaxoSmithKline's marketing of alli as an addition to a healthy lifestyle and not as the complete solution to consumers' weight-loss needs could prompt other pharmaceutical companies to follow similar marketing plans, according to researchers
You may also be interested in...
Chattem Flexes Earnings Guidance After Strong Start For Core Brands
Strong sales in January and high expectations for product initiatives planned for the remainder of the year prompted Chattem to increase its fiscal 2008 earnings estimates, the firm's executives told analysts Jan. 29
Chattem Sales Up 51% Behind Ongoing Push From J&J Acquisitions
Brands Chattem acquired from Johnson & Johnson and continued growth of its own Gold Bond and Icy Hot drove a 51 percent increase in third-quarter revenues, the firm reported Sept. 27
Alli Marketing Stresses Education, With Emphasis On Minority Groups – GSK
GlaxoSmithKline’s marketing strategy for its OTC weight-loss drug alli focuses on guiding consumers, particularly African Americans and Hispanics, in deciding whether they will follow the usage protocol before they buy the first-in-class product.